ClinicalTrials.gg
DrugBiological

Sotigalimab clinical trials

Also written APX005M.

studies test it
13
open now
0
in phase 3
0
first study started
2015

How each study uses sotigalimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Sotigalimab
3

Development codes

APX005M
12
EPI-0050
1
PYX-107
1

Other names

CD40 Agonistic Monoclonal Antibody APX005M
1

Studies by the year they started

13 studies that test it; most in 2017 (4)

Studies that test sotigalimab, by start year
YearStudies
20151
20161
20174
20183
20192
20201
20231

By phase

A phase 1/2 study counts in both.

Phase 1
9
Phase 2
7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 5 · Other 8

Apexigen America, Inc. (4) · M.D. Anderson Cancer Center (2) · Yale University (2) · Pediatric Brain Tumor Consortium (1) · Alexander Z. Wei, MD (1) · Parker Institute for Cancer Immunotherapy (1) · BioNTech US Inc. (1) · Nordic Society of Gynaecological Oncology - Clinical Trials Unit (1)

Often tested with

Tested in the same studies.

Synthetic Tumor-Associated Peptide Vaccine Therapy (1) · Cabiralizumab (1) · Nivolumab (1) · Personalized Peptide Cancer Vaccine NEO-PV-01 (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test sotigalimab.

Studies

Open first, then newest update. How each study uses sotigalimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 13

Given beside what is tested · 1 — sotigalimab is usual care or a partner of the new treatment

Codes

What other systems call sotigalimab · ClinicalTrials.gg INT001962

  • MeSH (NLM) C000723517sotigalimabOne source ClinicalTrials.gov
  • UNII (FDA) JEA93WJ5DGSOTIGALIMABOne source FDA
  • NCI Thesaurus C123734SotigalimabOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.